Comparison Overview

Philips BioTel Heart

VS

Eurofins

Philips BioTel Heart

1000 Cedar Hollow Rd., None, Malvern, PA, US, 19355
Last Update: 2025-12-01

CardioNet was just the beginning. Founded on an innovative, patented technology, the result of years of research and development, the company received FDA approval for its core monitoring technology and was the first to provide real-time, heartbeat-by-heartbeat, ECG monitoring, analysis and response, at home or away, 24/7/365. BioTelemetry Healthcare is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Company provides cardiologists and electrophysiologists who prefer to use a single source of cardiac monitoring services with a full spectrum of solutions, ranging from the differentiated Mobile Cardiac Outpatient Telemetry™ (“MCOT™”) service to wEvent, event, Holter, Pacemaker and International normalized ratio (“INR”) monitoring. INR monitoring is a measurement of blood coagulation in the circulatory system and is prescribed for patients on long term anticoagulation therapy.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 499
Subsidiaries: 0
12-month incidents
0
Known data breaches
1
Attack type number
2

Eurofins

Val Fleuri 23, None, Luxembourg, Luxembourg, LU, 1526
Last Update: 2025-12-01
Between 750 and 799

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 25,341
Subsidiaries: 21
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/biotelheart.jpeg
Philips BioTel Heart
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/eurofins.jpeg
Eurofins
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Philips BioTel Heart
100%
Compliance Rate
0/4 Standards Verified
Eurofins
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Philips BioTel Heart in 2025.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Eurofins in 2025.

Incident History — Philips BioTel Heart (X = Date, Y = Severity)

Philips BioTel Heart cyber incidents detection timeline including parent company and subsidiaries

Incident History — Eurofins (X = Date, Y = Severity)

Eurofins cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/biotelheart.jpeg
Philips BioTel Heart
Incidents

Date Detected: 8/2020
Type:Breach
Attack Vector: Unauthorized Access
Blog: Blog

Date Detected: 5/2019
Type:Data Leak
Attack Vector: Misconfiguration
Blog: Blog
https://images.rankiteo.com/companyimages/eurofins.jpeg
Eurofins
Incidents

No Incident

FAQ

Eurofins company demonstrates a stronger AI Cybersecurity Score compared to Philips BioTel Heart company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Philips BioTel Heart company has historically faced a number of disclosed cyber incidents, whereas Eurofins company has not reported any.

In the current year, Eurofins company and Philips BioTel Heart company have not reported any cyber incidents.

Neither Eurofins company nor Philips BioTel Heart company has reported experiencing a ransomware attack publicly.

Philips BioTel Heart company has disclosed at least one data breach, while the other Eurofins company has not reported such incidents publicly.

Neither Eurofins company nor Philips BioTel Heart company has reported experiencing targeted cyberattacks publicly.

Neither Philips BioTel Heart company nor Eurofins company has reported experiencing or disclosing vulnerabilities publicly.

Neither Philips BioTel Heart nor Eurofins holds any compliance certifications.

Neither company holds any compliance certifications.

Eurofins company has more subsidiaries worldwide compared to Philips BioTel Heart company.

Eurofins company employs more people globally than Philips BioTel Heart company, reflecting its scale as a Biotechnology Research.

Neither Philips BioTel Heart nor Eurofins holds SOC 2 Type 1 certification.

Neither Philips BioTel Heart nor Eurofins holds SOC 2 Type 2 certification.

Neither Philips BioTel Heart nor Eurofins holds ISO 27001 certification.

Neither Philips BioTel Heart nor Eurofins holds PCI DSS certification.

Neither Philips BioTel Heart nor Eurofins holds HIPAA certification.

Neither Philips BioTel Heart nor Eurofins holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

A weakness has been identified in codingWithElias School Management System up to f1ac334bfd89ae9067cc14dea12ec6ff3f078c01. Affected is an unknown function of the file /student-view.php of the component Edit Student Info Page. This manipulation of the argument First Name causes cross site scripting. Remote exploitation of the attack is possible. The exploit has been made available to the public and could be exploited. This product follows a rolling release approach for continuous delivery, so version details for affected or updated releases are not provided. Other parameters might be affected as well. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 3.3
Severity: LOW
AV:N/AC:L/Au:M/C:N/I:P/A:N
cvss3
Base: 2.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N
cvss4
Base: 4.8
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

By providing a command-line argument starting with a semi-colon ; to an API endpoint created by the EnhancedCommandExecutor class of the HexStrike AI MCP server, the resultant composed command is executed directly in the context of the MCP server’s normal privilege; typically, this is root. There is no attempt to sanitize these arguments in the default configuration of this MCP server at the affected version (as of commit 2f3a5512 in September of 2025).

Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Description

A weakness has been identified in winston-dsouza Ecommerce-Website up to 87734c043269baac0b4cfe9664784462138b1b2e. Affected by this issue is some unknown functionality of the file /includes/header_menu.php of the component GET Parameter Handler. Executing manipulation of the argument Error can lead to cross site scripting. The attack can be executed remotely. The exploit has been made available to the public and could be exploited. This product implements a rolling release for ongoing delivery, which means version information for affected or updated releases is unavailable. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 5.0
Severity: LOW
AV:N/AC:L/Au:N/C:N/I:P/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in Qualitor 8.20/8.24. Affected by this vulnerability is the function eval of the file /html/st/stdeslocamento/request/getResumo.php. Performing manipulation of the argument passageiros results in code injection. Remote exploitation of the attack is possible. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in Scada-LTS up to 2.7.8.1. Affected is the function Common.getHomeDir of the file br/org/scadabr/vo/exporter/ZIPProjectManager.java of the component Project Import. Such manipulation leads to path traversal. The attack may be launched remotely. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 6.5
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
cvss3
Base: 6.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X